BMJ 1997;315:841-846 (4 October)

Papers

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

M R Law, reader,a A K Hackshaw, lecturer a

a Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's and The Royal London School of Medicine, London EC1M 6BQ

Correspondence to: Dr Law

Objective: To determine the magnitude and importance of the relation between smoking, bone mineral density, and risk of hip fracture according to age.
Design: Meta-analysis of 29 published cross sectional studies reporting the difference in bone density in 2156 smokers and 9705 non-smokers according to age, and of 19 cohort and case-control studies recording 3889 hip fractures reporting risk in smokers relative to non-smokers.
Results: In premenopausal women bone density was similar in smokers and non-smokers. Postmenopausal bone loss was greater in current smokers than non-smokers, bone density diminishing by about an additional 2% for every 10 year increase in age, with a difference of 6% at age 80. In current smokers relative to non-smokers the risk of hip fracture was similar at age 50 but greater thereafter by an estimated 17% at age 60, 41% at 70, 71% at 80, and 108% at 90. These estimates of relative risk by age, derived directly from a regression analysis of the studies of smoking and hip fracture, were close to estimates using the difference in bone density between smokers and non-smokers and the association between bone density and risk of hip fracture. The estimated cumulative risk of hip fracture in women in England was 19% in smokers and 12% in non-smokers to age 85; 37% and 22% to age 90. Among all women, one hip fracture in eight is attributable to smoking. Limited data in men suggest a similar proportionate effect of smoking as in women. The association was not explained by smokers being thinner, younger at menopause, and exercising less nor by actions of smoking on oestrogen, but smoking may have a direct action on bone.
Conclusions: Hip fracture in old age is a major adverse effect of smoking after the menopause. The cumulative excess bone loss over decades is substantial, increasing the lifetime risk of hip fracture by about half.

Key messages

  • Smoking has no material effect on bone density in premenopausal women

  • Postmenopausal bone loss is greater in smokers—an additional 0.2% of bone mass each year. The cumulative effect of this over many years is substantial, with a difference of 6% at age 80

  • In current smokers relative to non-smokers the risk of hip fracture is estimated to be 17% greater at age 60, 41% greater at 70, 71% greater at 80, 108% greater at 90

  • The data in men are limited but suggest a similar proportionate effect in smokers

  • The cumulative risk of hip fracture to age 85 in women is 19% in smokers and 12% in non-smokers; to age 90 it is 37% and 22%

  • Among all women, one hip fracture in eight is attributable to smoking


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Relevant Article

Meta-analysis of cigarette smoking, bone mineral density, and risk of hip fracture
David J Torgerson, David M Reid, Marion K Campbell, Malcolm Law, and Allan Hackshaw
BMJ 1998 316: 1017. [Extract] [Full Text]

This article has been cited by other articles:

  • Wilsgaard, T., Emaus, N., Ahmed, L. A., Grimnes, G., Joakimsen, R. M., Omsland, T. K., Berntsen, G. R. (2009). Lifestyle Impact on Lifetime Bone Loss in Women and Men: The Tromso Study. Am J Epidemiol 169: 877-886 [Abstract] [Full text]  
  • Stolee, P., Poss, J., Cook, R. J., Byrne, K., Hirdes, J. P. (2009). Risk Factors for Hip Fracture in Older Home Care Clients. J Gerontol A Biol Sci Med Sci 64A: 403-410 [Abstract] [Full text]  
  • Dorn, L. D., Susman, E. J., Pabst, S., Huang, B., Kalkwarf, H., Grimes, S. (2008). Association of Depressive Symptoms and Anxiety With Bone Mass and Density in Ever-Smoking and Never-Smoking Adolescent Girls. Arch Pediatr Adolesc Med 162: 1181-1188 [Abstract] [Full text]  
  • Hadji, P., Body, J. -J., Aapro, M. S., Brufsky, A., Coleman, R. E., Guise, T., Lipton, A., Tubiana-Hulin, M. (2008). Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol 19: 1407-1416 [Abstract] [Full text]  
  • Liu, H., Paige, N. M., Goldzweig, C. L., Wong, E., Zhou, A., Suttorp, M. J., Munjas, B., Orwoll, E., Shekelle, P. (2008). Screening for Osteoporosis in Men: A Systematic Review for an American College of Physicians Guideline. ANN INTERN MED 148: 685-701 [Abstract] [Full text]  
  • Bushnell, B. D., Horton, J. K., McDonald, M. F., Robertson, P. G. (2008). Perioperative Medical Comorbidities in the Orthopaedic Patient. J Am Acad Orthop Surg 16: 216-227 [Abstract] [Full text]  
  • Sneve, M., Emaus, N., Joakimsen, R. M., Jorde, R. (2008). The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study. Eur J Endocrinol 158: 401-409 [Abstract] [Full text]  
  • Lata, P. F., Elliott, M. E. (2007). Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis. Nutr Clin Pract 22: 261-275 [Abstract] [Full text]  
  • Compston, J. (2007). Smoking and the Skeleton. J. Clin. Endocrinol. Metab. 92: 428-429 [Full text]  
  • Lorentzon, M., Mellstrom, D., Haug, E., Ohlsson, C. (2007). Smoking Is Associated with Lower Bone Mineral Density and Reduced Cortical Thickness in Young Men. J. Clin. Endocrinol. Metab. 92: 497-503 [Abstract] [Full text]  
  • Albertsson, D. M., Mellstrom, D., Petersson, C., Eggertsen, R. (2007). Validation of a 4-Item Score Predicting Hip Fracture and Mortality Risk Among Elderly Women. Ann Fam Med 5: 48-56 [Abstract] [Full text]  
  • Peel, N. M., McClure, R. J., Hendrikz, J. K. (2006). Health-protective behaviours and risk of fall-related hip fractures: a population-based case-control study. Age Ageing 35: 491-497 [Abstract] [Full text]  
  • Hinoi, E., Takarada, T., Tsuchihashi, Y., Fujimori, S., Moriguchi, N., Wang, L., Uno, K., Yoneda, Y. (2006). A Molecular Mechanism of Pyruvate Protection against Cytotoxicity of Reactive Oxygen Species in Osteoblasts. Mol. Pharmacol. 70: 925-935 [Abstract] [Full text]  
  • Hinoi, E., Fujimori, S., Wang, L., Hojo, H., Uno, K., Yoneda, Y. (2006). Nrf2 Negatively Regulates Osteoblast Differentiation via Interfering with Runx2-dependent Transcriptional Activation. J. Biol. Chem. 281: 18015-18024 [Abstract] [Full text]  
  • Emaus, N., Berntsen, G. K. R., Joakimsen, R., Fonnebo, V. (2006). Longitudinal Changes in Forearm Bone Mineral Density in Women and Men Aged 45-84 Years: The Tromso Study, a Population-based Study. Am J Epidemiol 163: 441-449 [Abstract] [Full text]  
  • Zhang, J., Munger, R. G., West, N. A., Cutler, D. R., Wengreen, H. J., Corcoran, C. D. (2006). Antioxidant Intake and Risk of Osteoporotic Hip Fracture in Utah: An Effect Modified by Smoking Status. Am J Epidemiol 163: 9-17 [Abstract] [Full text]  
  • Emaus, N., Berntsen, G. K. R., Joakimsen, R. M., Fonnebo, V. (2005). Longitudinal Changes in Forearm Bone Mineral Density in Women and Men Aged 25-44 Years: The Tromso Study: A Population-based Study. Am J Epidemiol 162: 633-643 [Abstract] [Full text]  
  • Smith, B J, McElroy, H J, Laslett, L L, Pile, K D, Phillips, P J, Phillipov, G, Evans, S M, Weekley, J S, Pilotto, L S (2005). Osteoporosis screening in people with airways disease. Chronic Respiratory Disease 2: 5-12 [Abstract]  
  • Scanlon, P. D., Connett, J. E., Wise, R. A., Tashkin, D. P., Madhok, T., Skeans, M., Carpenter, P. C., Bailey, W. C., Buist, A. S., Eichenhorn, M., Kanner, R. E., Weinmann, G., the Lung Health Study Research Group, (2004). Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II. Am. J. Respir. Crit. Care Med. 170: 1302-1309 [Abstract] [Full text]  
  • Porthouse, J., Birks, Y.F., Torgerson, D.J., Cockayne, S., Puffer, S., Watt, I. (2004). Risk factors for fracture in a UK population: a prospective cohort study. QJM 97: 569-574 [Abstract] [Full text]  
  • Smith, B J, Laslett, L L, Pile, K D, Phillips, P J, Phillipov, G, Evans, S M, Esterman, A J, Berry, J G (2004). Randomized controlled trial of alendronate in airways disease and low bone mineral density. Chronic Respiratory Disease 1: 131-137 [Abstract]  
  • Gourlay, M. L., Brown, S. A. (2004). Clinical Considerations in Premenopausal Osteoporosis. Arch Intern Med 164: 603-614 [Abstract] [Full text]  
  • Christodoulou, C, Cooper, C (2003). What is osteoporosis?. Postgrad. Med. J. 79: 133-138 [Abstract] [Full text]  
  • Katsura, H., Kida, K. (2002). A Comparison of Bone Mineral Density in Elderly Female Patients With COPD and Bronchial Asthma. Chest 122: 1949-1955 [Abstract] [Full text]  
  • Ilich, J. Z., Brownbill, R. A., Tamborini, L., Crncevic-Orlic, Z. (2002). To Drink or Not to Drink: How Are Alcohol, Caffeine and Past Smoking Related to Bone Mineral Density in Elderly Women?. J. Am. Coll. Nutr. 21: 536-544 [Abstract] [Full text]  
  • Tannenbaum, C., Clark, J., Schwartzman, K., Wallenstein, S., Lapinski, R., Meier, D., Luckey, M. (2002). Yield of Laboratory Testing to Identify Secondary Contributors to Osteoporosis in Otherwise Healthy Women. J. Clin. Endocrinol. Metab. 87: 4431-4437 [Abstract] [Full text]  
  • Peacock, M., Turner, C. H., Econs, M. J., Foroud, T. (2002). Genetics of Osteoporosis. Endocr. Rev. 23: 303-326 [Abstract] [Full text]  
  • Chapurlat, R. D., Ewing, S. K., Bauer, D. C., Cummings, S. R. (2001). Influence of Smoking on the Antiosteoporotic Efficacy of Raloxifene. J. Clin. Endocrinol. Metab. 86: 4178-4182 [Abstract] [Full text]  
  • Baron, J. A., Farahmand, B. Y., Weiderpass, E., Michaelsson, K., Alberts, A., Persson, I., Ljunghall, S. (2001). Cigarette Smoking, Alcohol Consumption, and Risk of Hip Fracture in Women. Arch Intern Med 161: 983-988 [Abstract] [Full text]  
  • Rosvold Berntsen, G. K., Fonnebo, V., Tollan, A., Johanne Sogaard, A., Magnus, J. H. (2001). Forearm Bone Mineral Density by Age in 7,620 Men and Women The Tromso Study, a Population-based Study. Am J Epidemiol 153: 465-473 [Abstract] [Full text]  
  • McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., Meunier, P. J., Wasnich, R. D., Greenwald, M., Kaufman, J.-M., Chesnut, Ph.D. C. H., Reginster, J.-Y. (2001). Effect of Risedronate on the Risk of Hip Fracture in Elderly Women. NEJM 344: 333-340 [Abstract] [Full text]  
  • Porter, S. E., Hanley, E. N. Jr (2001). The Musculoskeletal Effects of Smoking. J Am Acad Orthop Surg 9: 9-17 [Abstract] [Full text]  
  • Hoidrup, S., Prescott, E., Sorensen, T. I., Gottschau, A., Lauritzen, J. B., Schroll, M., Gronbak, M. (2000). Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol 29: 253-259 [Abstract] [Full text]  
  • Kato, I., Toniolo, P., Zeleniuch-Jacquotte, A., Shore, R. E, Koenig, K. L, Akhmedkhanov, A., Riboli, E. (2000). Diet, smoking and anthropometric indices and postmenopausal bone fractures: a prospective study. Int J Epidemiol 29: 85-92 [Abstract] [Full text]  
  • Shin, K. R. (1998). Review: smoking is associated with decreased bone mineral density and increased risk of hip fracture in postmenopausal women. Evid. Based Nurs. 1: 88-88 [Full text]  
  • Torgerson, D. J, Reid, D. M, Campbell, M. K, Law, M., Hackshaw, A. (1998). Meta-analysis of cigarette smoking, bone mineral density, and risk of hip fracture. BMJ 316: 1017-1017 [Full text]  
  • (1997). Hip Fracture: Another Danger of Smoking?. JWatch Women's Health 1997: 14-14 [Full text]  
  • (1997). HIP FRACTURE: ANOTHER DANGER OF SMOKING?. JWatch General 1997: 4-4 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ